1998
DOI: 10.1097/00004647-199809000-00002
|View full text |Cite
|
Sign up to set email alerts
|

Cerebral Blood Flow Measurements by Magnetic Resonance Imaging Bolus Tracking: Comparison with [15O]H2O Positron Emission Tomography in Humans

Abstract: Summary: In six young, healthy volunteers, a novel method to determine cerebral blood flow (CBF) using magnetic reso nance (MR) bolus tracking was compared with [,sO]H20 pos itron emission tomography (PET). The method yielded para metric CBF images with tissue contrast in good agreement withRecent results indicate that it may be possible to mea sure CBF by dynamic magnetic resonance imaging (MRI) of paramagnetic contrast agent bolus passage (0stergaard et aI., 1996a). Because of the complexity of susceptibilit… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

11
175
0
2

Year Published

2000
2000
2009
2009

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 211 publications
(188 citation statements)
references
References 12 publications
11
175
0
2
Order By: Relevance
“…20. The procedure F s3c is generally nonlinear, and hence rescaling by multiplication of concentration curves as employed previously (6,(13)(14)(15)(16)(17) is not equivalent to multiplication of signal curves and may distort the AIF (4). We instead apply the multiplication to the MR signal (Eq.…”
Section: Pve and Aif Rescalingmentioning
confidence: 99%
See 1 more Smart Citation
“…20. The procedure F s3c is generally nonlinear, and hence rescaling by multiplication of concentration curves as employed previously (6,(13)(14)(15)(16)(17) is not equivalent to multiplication of signal curves and may distort the AIF (4). We instead apply the multiplication to the MR signal (Eq.…”
Section: Pve and Aif Rescalingmentioning
confidence: 99%
“…Furthermore, such an approach increases quantification errors due to delay and dispersion of the bolus (11), which on the contrary motivates the use of a local AIF (12). Thus several studies, either based on dynamic susceptibility contrast (DSC) perfusion imaging (6,13,(15)(16)(17)(18)(19) or dynamic contrast-enhanced (DCE) perfusion imaging (14), have compensated the PVE by a multiplicative rescaling. The rescaling is either applied to the AIF (6,(13)(14)(15)(16)(17) or the CBF estimate (18,19), and is often based on normalization to a venous outflow function (VOF) (14,16 -18).…”
mentioning
confidence: 99%
“…In an attempt to obtain absolute flow values from EPI experiments, Østergaard et al assumed proportionality between the area of the AIF and the injected contrast dose, using water clearance PET as a calibration method. This approach provided reproducible absolute CBF measurements in animal hypercapnia studies (6) and in humans (43). However, this approach may be too crude to allow general use in patients with severe cardiac or cerebrovascular disease.…”
Section: Quantificationmentioning
confidence: 99%
“…The AIF signal should be on the same scale as the tissue curve, or it should be possible to place the AIF signal on the same scale as the tissue curve by applying a relative scale factor (similar to the approach used in Ref. 55). While the use of a ⌬R2* AIF with a ⌬R2* tissue curve may seem appealing because the same signal type is used, both the ⌬R2* and the ⌬ AIF curves require scaling to place them on the same concentration scale as the tissue ⌬R2* data.…”
Section: Scale Factors and Quantitationmentioning
confidence: 99%